Discover trends, market shifts, and competitive outlooks for the anti-hypertensive drugs industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What is the Projected CAGR for the Anti-Hypertensive Drugs Market Size from 2025 to 2034?

In recent years, there has been a stable increase in the market size for anti-hypertensive drugs. The value is projected to increase from $36.66 billion in 2024 to $37.5 billion in 2025, equating to a compound annual growth rate (CAGR) of 2.3%. This growth during the historical period can be linked back to influences such as environmental factors and lifestyle choices, previous market competition, customary treatment preferences, the state of the economy, and past global health trends.

Over the next few years, the market size of anti-hypertensive drugs is anticipated to experience slight expansion, reaching $40.41 billion by 2029 with a compound annual growth rate (CAGR) of 1.9%. This predicted growth during the forecast period is due to a variety of factors, including affordability and cost-effectiveness, innovative therapeutic developments, epidemiological patterns, regulatory modifications and approvals, demographic shifts due to aging population, as well as alterations in healthcare policies and reimbursement. Some of the key trends for the forecast period comprise therapeutic innovation, epidemiological transitions, regulatory environment changes, healthcare policy amendments and progress in diagnosis and monitoring.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2410&type=smp

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theAnti-Hypertensive Drugs Market?

The expansion of the anti-hypertensive drug market is majorly propelled by a sedentary lifestyle. Factors such as junk food consumption, an absence of a well-balanced and healthy diet, and insufficient sleep from irregular work hours have led to a rise in hypertension. Hypertension is responsible for about 45% of heart disease-related deaths and 51% of stroke-related deaths. Once patients are diagnosed with this condition, it is necessary to intake drugs to manage hypertension depending on its severity. For example, in May 2023, the National Health Service, a government department based in England, reported that the prevalence of hypertension significantly increases with age, starting from 9% in adults between the ages of 16 to 44 and then skyrocketing to 60% in individuals aged 65 and older. This ever-present requirement for the product fuels its enduring demand, acting as a key driver for the market’s growth.

Which Segments in the Anti-Hypertensive Drugs Offer the Most Growth?

The anti-hypertensive drugs market covered in this report is segmented –

1) By Therapeutics: Diuretics, Angiotensin Receptor Blockers (ARBs), Angiotensin Converting Enzyme (ACE) Inhibitors, Beta Blockers, Alpha Blockers, Calcium Channel Blockers, Renin Inhibitors, Vasodilators

2) By Disease Source: Primary Hypertension, Secondary Hypertension

3) By End Users: Hospitals, Clinics, Homecare

Subsegments:

1) By Diuretics: Thiazide Diuretics, Loop Diuretics, Potassium-Sparing Diuretics

2) By Angiotensin Receptor Blockers (ARBs): Losartan, Valsartan, Irbesartan, Candesartan

3) By Angiotensin Converting Enzyme (ACE) Inhibitors: Enalapril, Lisinopril, Ramipril, Benazepril

4) By Beta Blockers: Metoprolol, Atenolol, Carvedilol, Bisoprolol

5) By Alpha Blockers: Doxazosin, Prazosin, Terazosin

6) By Calcium Channel Blockers: Amlodipine, Diltiazem, Verapamil, Nifedipine

7) By Renin Inhibitors: Aliskiren

8) By Vasodilators: Hydralazine, Minoxidil

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=2410&type=smp

What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theAnti-Hypertensive Drugs Market?# Market?

North America was the largest region in the anti-hypertensive drugs market in 2024. The Middle East is expected to be the largest growing region in the global anti-hypertensive drugs market during the forecast period. The regions covered in the anti-hypertensive drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Current Market Growth and Trends in the Anti-Hypertensive Drugs Industry?

Top firms in the anti-hypertensive drugs industry are concentrating on developing novel products like Metoprolol Succinate Extended-Release Tablets to gain a competitive market advantage. Metoprolol Succinate Extended-Release Tablets, designed to treat hypertension patients, are a type of anti-hypertensive medication. To illustrate, in June 2023, Granules India Limited, a pharmaceutical producer based in India, introduced Metoprolol Succinate Extended-Release Tablets that had garnered approval from the Food and Drug Administration (FDA), an institution based in the US. These tablets, which are anti-hypertensive medications purposed for hypertension management and reduction of blood pressure, come in different dosage levels: 25mg, 50mg, 100mg, and 200mg. They consist of beta-blockers that decelerate the heart’s pace, lessen its burden, and decrease blood pressure.

View the full report here:

https://www.thebusinessresearchcompany.com/report/anti-hypertensive-drugs-global-market-report

What Are the Key Elements That Define the Anti-Hypertensive Drugs Market?

Anti-hypertensive drugs refer to a group of medications used to treat high blood pressure (high blood pressure). The goal of antihypertensive therapy is to prevent the negative effects of high blood pressure, such as myocardial infarction and stroke.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2410

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model